Primary immunodeficiency diseases in Latin America: Proceedings of the Second Latin American Society for Immunodeficiencies (LASID) Advisory Board


Autoria(s): LEIVA, L. E.; BEZRODNIK, L.; OLEASTRO, M.; CONDINO-NETO, A.; COSTA-CARVALHO, B. T.; GRUMACH, A. Sevciovic; ESPINOSA-ROSALES, F. J.; FRANCO, J. Luis; KING, A.; INOSTROZA, J.; QUEZADA, A.; PORRAS, O.; SORENSEN, R. U.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

20/10/2012

20/10/2012

2011

Resumo

Early diagnosis and appropriate therapy are essential for the best prognosis and quality of life in patients with primary immunodeficiency diseases (PIDDs). Experts from several Latin American countries have been meeting on a regular basis as part of an ongoing effort to improve the diagnosis and treatment of PIDD in this region. Three programmes are in development that will expand education and training and improve access to testing facilities throughout Latin America. These programmes are: an educational outreach programme (The L-Project); an immunology fellowship programme; and the establishment of a laboratory network to expand access to testing facilities. This report provides the status of these programmes based on the most recent discussions and describes the next steps toward full implementation of these programmes. (C) 2010 SEICAP. Published by Elsevier Espana, S.L. All rights reserved.

Baxter Biosciences

Baxter

Identificador

ALLERGOLOGIA ET IMMUNOPATHOLOGIA, v.39, n.2, p.106-110, 2011

0301-0546

http://producao.usp.br/handle/BDPI/28231

10.1016/j.aller.2010.10.007

http://dx.doi.org/10.1016/j.aller.2010.10.007

Idioma(s)

eng

Publicador

ELSEVIER DOYMA SL

Relação

Allergologia Et Immunopathologia

Direitos

restrictedAccess

Copyright ELSEVIER DOYMA SL

Palavras-Chave #Primary immunodeficiency diseases #Latin America #Diagnosis #Treatment #Education #Registry #DEFICIENCY #PATIENT #Allergy #Immunology
Tipo

article

original article

publishedVersion